Precision Breast Cancer Medicine: Early Stage Triple Negative Breast Cancer-A Review of Molecular Characterisation, Therapeutic Targets and Future Trends.

Saved in:

Bibliographic Details
Title:	Precision Breast Cancer Medicine: Early Stage Triple Negative Breast Cancer-A Review of Molecular Characterisation, Therapeutic Targets and Future Trends.
Authors:	Pinilla K; Precision Breast Cancer Institute, University of Cambridge, Cambridge, United Kingdom.; Department of Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.; Cancer Research UK Cambridge Centre, Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom., Drewett LM; Precision Breast Cancer Institute, University of Cambridge, Cambridge, United Kingdom.; Department of Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom., Lucey R; Precision Breast Cancer Institute, University of Cambridge, Cambridge, United Kingdom.; Department of Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom., Abraham JE; Precision Breast Cancer Institute, University of Cambridge, Cambridge, United Kingdom.; Department of Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.; Cancer Research UK Cambridge Centre, Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom.
Source:	Frontiers in oncology [Front Oncol] 2022 Aug 08; Vol. 12, pp. 866889. Date of Electronic Publication: 2022 Aug 08 (Print Publication: 2022).
Publication Type:	Journal Article; Review
Journal Info:	Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	2234-943X
DOI:	10.3389/fonc.2022.866889